Dementias pp 51-76 | Cite as

Classification and Diagnosis of Dementias

  • F. Boller
  • L. Traykov


Dementia is a clinical state characterized by a decline in multiple cognitive functions that interferes with a subject’s ability to function on a daily basis, with a preserved level of consciousness, at least up to its most advanced stage. In an effort to operationalize the definition of dementia, attempts have been made to specify the type and degree of the cognitive decline. Most criteria require that multiple domains of cognitive functions be affected and that the cognitive dysfunction be clinically significant. This approach helps distinguish the demented patient from patients with restricted brain lesions [e.g., with a cerebrovascular accident (CVA) producing aphasia] and from the cognitive changes that occur with normal aging.


Progressive Supranuclear Palsy Progressive Supranuclear Palsy Diffuse Lewy Body Disease Subcortical Dementia Idiopathic Basal Ganglion Calcification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Derouesne C, Kalafat M, Guez D, Malbezin M, Poitrenaud J (1994) The age-associated memory impairment construct revisited. Comments and recommendations of a French-speaking work group. Int J Geriatr Psychiatry 9: 577–587CrossRefGoogle Scholar
  2. 2.
    Levy R (1994) Aging-associated cognitive decline. Int Psychogeriatr 6: 63–68PubMedCrossRefGoogle Scholar
  3. 3.
    World Health Organisation (1993) The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. World Health Organisation, GenevaGoogle Scholar
  4. 4.
    American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. American Psychiatric Association, Washington DCGoogle Scholar
  5. 5.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DCGoogle Scholar
  6. 6.
    Forette F, Henry JF, Orgogozo JM, Pere JF, Hugonot L, Israel L, Loria Y, Goulley F, Lallemand A, Boller F (1989) The reliability of clinical criteria for the diagnosis of dementia: a longitudinal multicentric study. Arch Neurol 46: 646–648PubMedCrossRefGoogle Scholar
  7. 7.
    Baldereschi M, Amato MP, Nencini P, et al (1994) Cross-national interrater agreement on the clinical diagnostic criteria for dementia. Neurology 44: 239–242PubMedCrossRefGoogle Scholar
  8. 8.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944PubMedCrossRefGoogle Scholar
  9. 9.
    Albert MS (1988) Cognitive function. In: Albert MS, Moss MB (eds) Geriatric neuropsychology. Guilford, New York, pp 33–53Google Scholar
  10. 10.
    Boller F, Marcie P, Traykov L (1996) Neuropsychologie du vieillissement normal. In: Botez MI (ed) Neuropsychologie clinique et neurologie du comportement. Masson/Presse Universitaire du Quebec, Paris, pp 527–548Google Scholar
  11. 11.
    Horn JK, Cattell RB (1967) Age differences in fluid and crystallized intelligence. Acta Psychol 26: 107–129CrossRefGoogle Scholar
  12. 12.
    Hochanadel G, Kaplan E (1984) Neuropsychology of normal aging. In: Albert ML (ed) Clinical neurology of aging. Lexington Books, Lexington, pp 121–132Google Scholar
  13. 13.
    Kral VA (1962) Senescent forgetfulness: benign and malignant. J Can Med Assoc 86: 257–260Google Scholar
  14. 14.
    Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. Dev Neuropsychol 2: 261–276CrossRefGoogle Scholar
  15. 15.
    Blackford RC, La Rue A (1989) Criteria for diagnosing AAMI: proposed improvement from the field. Dev Neuropsychol 5: 295–306CrossRefGoogle Scholar
  16. 16.
    Creasey H, Schwartz M, Frederickson H, Haxby J, Rapoport S (1986) Quantitative computed tomography in dementia of the Alzheimer type. Neurology 36: 1563–1568PubMedCrossRefGoogle Scholar
  17. 17.
    Von Stockert F (1932) Subkorticale Demenz. Archiv Psychiatrie 97: 77–100CrossRefGoogle Scholar
  18. 18.
    Albert M, Feldman R, Willis A (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 121–130PubMedCrossRefGoogle Scholar
  19. 19.
    McHugh P, Folstein M (1975) Psychiatric syndromes of Huntington’s chorea: a clinical and phenomenological study. In: Benson FD, Blumer D (eds) Psychiatric aspects of neurologic disease. Grune and Stratton, New York, pp 267–286Google Scholar
  20. 20.
    Mandell A, Albert M (1990) History of subcortical dementia. In: Cummings J (ed) Subcortical dementia. Oxford University Press, New York, pp 17–30Google Scholar
  21. 21.
    Cummings JL, Benson DF (1983) Dementia. A clinical approach. Butterworths, Stoneham, pp 89–103Google Scholar
  22. 22.
    Bruyn G, Bots G, Dom R (1979) Huntington’s chorea: current neuropathological status. In: Chace T, Wexler N, Barbeau A (eds) Huntington’s disease (Advances in neurology, vol 23). Raven, New York, pp 83–93Google Scholar
  23. 23.
    Bondareff W, Mountjoy C, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32: 164–168PubMedCrossRefGoogle Scholar
  24. 24.
    Whitehouse P (1986) The concept of subcortical dementia. Another look. Ann Neurol 19: 1–6PubMedCrossRefGoogle Scholar
  25. 25.
    Mayeux R, Stern Y, Rosen J, Benson DF (1983) Is “subcortical dementia” a recognizable clinical entity? Ann Neurol 14: 278–283PubMedCrossRefGoogle Scholar
  26. 26.
    Taylor AE, Saint-Cyr JA, Lang AE (1986) Frontal lobe dysfunction in Parkinson’s disease. The cortical focus of neostriatal outflow. Brain 109: 845–883PubMedCrossRefGoogle Scholar
  27. 27.
    Brandt J (1991) Cognitive impairments in Huntington’s disease: insights into the neuropsychology of the striatum. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 5. Elsevier, Amsterdam, pp 241–264Google Scholar
  28. 28.
    Blin J, Baron J, Dubois B, Pillon B, Cambon J, Agid Y (1990) Positron emission tomography study in progressive supranuclear palsy: brain hypometabolic pattern and clinico-metabolic correlations. Arch Neurol 47: 747–752PubMedCrossRefGoogle Scholar
  29. 29.
    Everall I, Luthbert P, Lantos P (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119–1121PubMedCrossRefGoogle Scholar
  30. 30.
    Freedman M, Albert M (1985) Subcortical dementia. In: Frederiks JAM (ed) Handbook of clinical neurology. Elsevier, Amsterdam, pp 311–316Google Scholar
  31. 31.
    Maruff P, Currie J, Malone V, McArthur-Jackson C, Mulhall B, Benson E (1994) Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery. Arch Neurol 51: 689–695PubMedCrossRefGoogle Scholar
  32. 32.
    Dubois B, Boller F, Pillon B, Agid Y (1991) Cognitive deficits in Parkinson’s disease. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 5. Elsevier, Amsterdam, pp 333–356Google Scholar
  33. 33.
    Boller F, Duyckaerts C (1996) Alzheimer’s disease: clinical and anatomical aspects. In: Feinberg TE, Farah MJ (eds) Behavioral neurology and neuropsychology. McGraw Hill, New York, pp 521–544Google Scholar
  34. 34.
    Boller F (1991) Hallazgos neuropsicologicos en 1a enfermidad de Alzheimer. In: Tolosa E, Bermejo F, Boller F (eds) Demencia senil. Springer-Verlag Iberica, Barcelona, pp 65–73Google Scholar
  35. 35.
    Huff FJ, Becker JT, Belle SH, Nebes R, Holland A, Boller F (1987) Cognitive deficits and diagnosis of Alzheimer’s disease. Neurology 36: 1198–1214Google Scholar
  36. 36.
    Tierny MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathological study of 57 cases. Neurology 38: 359–364CrossRefGoogle Scholar
  37. 37.
    Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C, and the CERAD investigators (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39: 1159–1165Google Scholar
  38. 38.
    Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572PubMedCrossRefGoogle Scholar
  39. 39.
    Todorov A, Go R, Constantinidis J, Elston R (1975) Specificity of the clinical diagnosis of dementia. J Neurol Sci 26: 81–98PubMedCrossRefGoogle Scholar
  40. 40.
    Boller F, Lopez OL, Moossy J (1989) Diagnosis of dementia: clinicopathologic correlations. Neurology 39: 76–79PubMedCrossRefGoogle Scholar
  41. 41.
    Martin EM, Wilson RS, Penn RD, Fox JH, Clasen RA, Savoy SM (1987) Cortical biopsy results in Alzheimer’s disease: correlation with cognitive deficits. Neurology 37: 1201–1204PubMedCrossRefGoogle Scholar
  42. 42.
    Morris JC, Berg L, Fulling K, Torack AM, McKeel DW (1987) Validation of clinical diagnostic criteria in senile dementia of the Alzheimer type. Ann Neurol 22: 122Google Scholar
  43. 43.
    Heyman A, Fillenbaum G, Mirra S, and participating CERAD neuropathologists (1992) Clinical misdiagnosis of Alzheimer’s disease. A review of CERAD autopsy findings. Ann Neurol 32: 270–271Google Scholar
  44. 44.
    Hachinski V (1992) Preventable senility — a call for action against the vascular dementias. Lancet 340: 645–648PubMedCrossRefGoogle Scholar
  45. 45.
    Tatemichi TK, Sacktor N, Mayeux R (1994) Dementia associated with cerebrovascular disease, other degenerative disease, and metabolic disorders. In: Terry R, Katzman R, Bick KL (ed) Alzheimer disease. Raven, New York, pp 123–167Google Scholar
  46. 46.
    Erkinjuntti T (1994) Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 5: 189–192PubMedGoogle Scholar
  47. 47.
    Caplan L (1996) From vascular lesions to dementia. In: Forette F, Christen Y, Boller F (eds) La demence: pourquoi? Fondation Nationale de Gerontologie, Paris, pp 157–174Google Scholar
  48. 48.
    Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 42: 473–480PubMedCrossRefGoogle Scholar
  49. 49.
    Roman GC, Tatemichi TK, Erkinjuntti T, et al (1993) Vascular dementia: diagnostic criteria for research studies. Neurology 43: 250–260PubMedCrossRefGoogle Scholar
  50. 50.
    Erkinjuntti T (1987) Differential diagnosis between Alzheimer’s disease and vascular dementia: evaluation of common clinical methods. Acta Neurol Scand 76: 433–442PubMedCrossRefGoogle Scholar
  51. 51.
    Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, and participating CERAD neuropathologists (1991) The Consortium to Establish a Registry in Alzheimer’s disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486Google Scholar
  52. 52.
    Hachinski VC, Iliff LD, Zilhka E, et al (1975) Cerebral blood flow in dementia. Arch Neurol 32: 732–737CrossRefGoogle Scholar
  53. 53.
    Loeb C, Gandolfo C (1983) Diagnostic evaluation of degenerative and vascular dementia. Stroke 14: 399–401PubMedCrossRefGoogle Scholar
  54. 54.
    Knopman D (1993) The non-Alzheimer degenerative dementias. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 8. Elsevier, Amsterdam, pp 295–313Google Scholar
  55. 55.
    Mendez MF, Selwood A, Mastri AR, Frey WH (1993) Pick’s disease versus Alzheimer’s disease: a comparison of clinical characteristics. Neurology 43: 289–292PubMedCrossRefGoogle Scholar
  56. 56.
    Escourolle R (1956) La maladie de Pick. Etude d’ensemble et synthèse anatomo-clinique. Masson, ParisGoogle Scholar
  57. 57.
    Tissot R, Constantinidis J, Richard J (1975) La maladie de Pick. Masson, ParisGoogle Scholar
  58. 58.
    Knopman DS, Christensen KJ, Schut LJ, et al (1989) The spectrum of imaging and neuropsychological findings in Pick’s disease. Neurology 39: 362–368PubMedCrossRefGoogle Scholar
  59. 59.
    Mesulam MM (1982) Slowly progressive aphasia without generalized dementia. Ann Neurol 11: 592–598PubMedCrossRefGoogle Scholar
  60. 60.
    Cole M, Wright D, Banker BQ (1979) Familial aphasia due to Pick’s disease. Ann Neurol 6: 158Google Scholar
  61. 61.
    Wechsler AF (1977) Presenile dementia presenting as aphasia. J Neurol Neurosurg Psychiatry 40: 303–305PubMedCrossRefGoogle Scholar
  62. 62.
    Weintraub S, Mesulam MM (1993) Four neuropsychological profiles in dementia. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 8. Elsevier, Amsterdam, pp 253–282Google Scholar
  63. 63.
    Kertesz A, Munoz DG (1994) The pathology and nosology of primary progressive aphasia. Neurology 44: A259CrossRefGoogle Scholar
  64. 64.
    Fustinoni O, Mangone CA, Abiusi GRP, et al (1994) Primary progressive aphasia: clinical subtypes, with one postmortem study. Neurology 44: A387Google Scholar
  65. 65.
    Kertesz A (1996) Pick complex and Pick’s disease, the nosology of frontal lobe dementia, primary progressive aphasia, and corticobasal ganglionic degeneration. Eur J Neurol 3: 280–282PubMedCrossRefGoogle Scholar
  66. 66.
    Duyckaerts C, Dürr A, Uchihara T, Boller F, Hauw JJ (1996) Pick complex: too simple? Eur J Neurol 3: 283–286PubMedCrossRefGoogle Scholar
  67. 67.
    Morris JC, Cole M, Banker BQ, Wright D (1984) Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 16: 455–466PubMedCrossRefGoogle Scholar
  68. 68.
    Brun A (1987) Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 6: 193–208PubMedCrossRefGoogle Scholar
  69. 69.
    Neary D, Snowden JS, Bowen DM, et al (1986) Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 49: 163–174PubMedCrossRefGoogle Scholar
  70. 70.
    The Lund and Manchester Groups (1994) Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57: 416–418CrossRefGoogle Scholar
  71. 71.
    Lhermitte F, Pillon B, Serdaru M (1986) Human autonomy and the frontal lobes. Ann Neurol 19: 326–334PubMedCrossRefGoogle Scholar
  72. 72.
    Kosaka K (1993) Dementia and neuropathology in Lewy body disease. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Parkinson’s disease. From basic research to treatment (Advances in neurology, vol 60). Raven, New York, pp 456–463Google Scholar
  73. 73.
    Hansen L, Salmon D, Galasko D, et al (1990) Lewy body variant of Alzheimer’s disease: a clinical and pathological entity. Neurology 40: 1–8PubMedCrossRefGoogle Scholar
  74. 74.
    Joachim CL, Morris JH, Selkoe DJ (1988) Cinically diagnosed Alzheimer’s disease: autopsy results in 150 cases. Ann Neurol 24: 50–56PubMedCrossRefGoogle Scholar
  75. 75.
    Lennox G (1992) Lewy body dementia. In: Rossor MN (ed) Baillière’s clinical neurology. Baillière Tindall, London, pp 653–676Google Scholar
  76. 76.
    Boller F, Duyckaerts C (1994) Dementia in diffuse Lewy body disease. In: Alberca R, Boller F (eds) Early diagnosis of Alzheimer disease. Aula Medica, Madrid, pp 156–165Google Scholar
  77. 77.
    Boller F, Mizutani T, Roessmann U, Gambetti PL (1980) Parkinson disease, dementia and Alzheimer disease: clinico-pathological correlations. Ann Neurol 7: 329–335PubMedCrossRefGoogle Scholar
  78. 78.
    Gnanalingham K, Byrne J, Thornton A (1996) Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 347: 696–697PubMedCrossRefGoogle Scholar
  79. 79.
    Crystal HA, Dickson DW, Lizardi JE, Davies P, Wolfson LI (1990) Antemortem diagnosis of diffuse Lewy body disease. Neurology 40: 1523–1528PubMedCrossRefGoogle Scholar
  80. 80.
    Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38: 1520–1528PubMedCrossRefGoogle Scholar
  81. 81.
    Mahieux F, Michelet D, Manifacier MJ, Fenelon G, Boller F, Guillard A (1992) Mini Mental Parkinson: validation study of the revised form. J Neurol 239: S120Google Scholar
  82. 82.
    Brown R, Marsden C (1988) “Subcortical dementia”: the neuropsychological evidence. Neurosciences 25: 363–387CrossRefGoogle Scholar
  83. 83.
    Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuclear dystonia and dementia. Arch Neurol 10: 333–359PubMedCrossRefGoogle Scholar
  84. 84.
    Pillon B, Dubois B, Ploska A, Agid Y (1991) Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy. Neurology 41: 634–643PubMedCrossRefGoogle Scholar
  85. 85.
    Mann DMA, South PW, Snowden JS, Neary D (1993) Dementia of frontal lobe type: neurophatology and immunohistochemistry. J Neurol Neurosurg Psichiatry 56: 605–614CrossRefGoogle Scholar
  86. 86.
    Lees AJ (1987) The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). In: Marsden CD, Fahn S (eds) Movement disorders. Butterworths, London, pp 272–287Google Scholar
  87. 87.
    Kurtzke J (1979) Huntington’s disease: mortality and morbidity data from outside the United States. Adv Neurol 23: 13–25Google Scholar
  88. 88.
    Conneally P (1984) Huntington disease: genetics and epidemiology. Am J Hum Gen 36: 506–526Google Scholar
  89. 89.
    Albert M, Butters N, Brandt J (1981) Patterns of remote memory in amnesic and demented patients. Arch Neurol 38: 495–500PubMedCrossRefGoogle Scholar
  90. 90.
    Klawans H, Goetz C, Perlik S (1980) Presymptomatic and early detection of Huntington’s disease. Ann Neurol 8: 343–347PubMedCrossRefGoogle Scholar
  91. 91.
    Mazziotta JC, Phelbs ME, Pahl JJ, et al (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington’s disease. N Engl J Med 316: 357–362PubMedCrossRefGoogle Scholar
  92. 92.
    Snider W, Simpson D, Nielsen S, Gold J, Metroka C, Posner J (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14: 403–418PubMedCrossRefGoogle Scholar
  93. 93.
    Navia B, Jordan B, Price R (1986) The AIDS dementia complex. I. Clinical features. Ann Neurol 19: 517–524PubMedCrossRefGoogle Scholar
  94. 94.
    Habib M, Poncet M (1988) Loss of drive, interest and affect (“athymormia syndrome”) with lacunar lesions of the striatum. Rev Neurol 144: 571–577PubMedGoogle Scholar
  95. 95.
    Fuhrer R, Rouillon F (1989) La version française de l’echelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l’echelle d’auto/valuation. Psychiatr Psychobiol 4: 163–166Google Scholar
  96. 96.
    Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann Intern Med 107: 828–836PubMedGoogle Scholar
  97. 97.
    McArthur J, Cohen B, Scines O, et al (1989) Low prevalence of neurological an neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the multicentral AIDS cohort study. Ann Neurol 26: 601–609PubMedCrossRefGoogle Scholar
  98. 98.
    Scines OA, Miller E, McArthur J, et al (1990) HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology 40: 204–208CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • F. Boller
  • L. Traykov

There are no affiliations available

Personalised recommendations